Thursday , November 23 2017
Home / Resources / Products / Medtronic’s Hybrid Closed Loop System in Clinical Trial

Medtronic’s Hybrid Closed Loop System in Clinical Trial

Researchers are testing Medtronic’s 670G "hybrid-closed loop" system (insulin pump + Enlite 3 CGM sensor) in people with type 1 diabetes. Based on the Enlite 3 CGM reading every five minutes, the 670G pump’s software automatically increases/decreases insulin delivery to target a blood glucose of 120 mg/dl. The 670G algorithm is fully integrated within the pump itself, so a patient only needs to wear the Enlite 3 CGM sensor and the MiniMed 670G pump – no need to carry a separate CGM receiver. The 670G is considered a "hybrid-closed loop" because the user still needs to bolus for meals and notify the system of exercise. For more information, please go to the trial’s webpage and view the contact information specific to each enrolling location. http://clinicaltrials.gov/ct2/show/NCT02463097?term=hybrid+closed+loop&rank=2